Bloomage
Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel
Bloomage, founded in January, 2000 and headquartered in Jinan, is a hyaluronic acid R&D manufacturer. The founder is Zhao Yan. Listed on the SSE on November 6, 2019, the company's major shareholders are Huaxi Xinyu Investment Co., Ltd., China Life Chengda (Shanghai) Health Industry Equity Investment Center (LP) and Ningxia Yingrui Wuyuan PE Partnership Enterprise (LP). Rivals that have direct and indirect competition with Bloomage include Well, Boai Nky, Pharm Agra, Mylan, etc.
Polish President: the issue of providing fighters to Ukraine should be jointly decided by NATO countries
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Technology, Real Estate, IndustrialsTech for Global, Globalization Footprints of the Established and the New
Daquan energy: the polysilicon sales volume in the first quarter is expected to increase by 72.33% - 76.98% year-on-year
NK Celltech Receives a Series A Round of Funding Worth More Than CNY 100 Million
NK Celltech recently received a Series A round of funding totaling more than CNY 100 million. Huagai Capital led this round of funding, which was followed by CASVC, Unifortune, 呈益资本, Sirius Capital, and QJ Capital.
Jul 01, 2022 03:58 PM
Dialysis Provider Dakang Medical Raised CNY 400 Million Yuan in Series E Round.
This financing round was led by Ganjiang Kai Investment, a state-owned investment platform in Ganjiang, Jiangxi Province, and was followed by Central Enterprises Poor Regions Industry Investment Fund Co., and Neovision Capital.
Jun 30, 2022 04:16 PM
Baijiu plate strength, mouth cellar line exceeds 10%
Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.